These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 37789778

  • 1. Hydrogel-based miR-192 delivery inhibits the development of hepatocellular carcinoma by suppressing the GSK3β/Wnt/β-catenin pathway.
    Yang Q, Zhuge X, Lin W, Yu W, Zhu Y, Shi C, Shi Z.
    Neoplasma; 2023 Aug; 70(4):555-565. PubMed ID: 37789778
    [Abstract] [Full Text] [Related]

  • 2. miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10.
    Cheng X, Wu C, Xu H, Zou R, Li T, Ye S.
    Aging (Albany NY); 2024 Feb 15; 16(4):3716-3733. PubMed ID: 38364252
    [Abstract] [Full Text] [Related]

  • 3. P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer through the Wnt/β-catenin signaling pathway.
    Zhao J, Wang Y, Han M, Lu H, Chen X, Liu S, Yuan X, Han K, Liang P, Cheng J.
    Cancer Sci; 2020 Mar 15; 111(3):994-1007. PubMed ID: 31746531
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway.
    Xu H, Li B.
    Bioengineered; 2022 May 15; 13(5):12876-12887. PubMed ID: 35609318
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H, Li B, Yang J.
    Biomed Pharmacother; 2018 Nov 15; 107():754-762. PubMed ID: 30142536
    [Abstract] [Full Text] [Related]

  • 6. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY, Xue M, Zhang QC, Su CF.
    Oncotarget; 2017 Feb 28; 8(9):15507-15519. PubMed ID: 28099945
    [Abstract] [Full Text] [Related]

  • 7. microR-505/heterogeneous nuclear ribonucleoprotein M inhibits hepatocellular carcinoma cell proliferation and induces cell apoptosis through the Wnt/β-catenin signaling pathway.
    Chi X, Jiang Y, Chen Y, Lv L, Chen J, Yang F, Zhang X, Pan F, Cai Q.
    Biomark Med; 2020 Jul 28; 14(11):981-996. PubMed ID: 32940078
    [Abstract] [Full Text] [Related]

  • 8. Over-expression of microRNA-940 promotes cell proliferation by targeting GSK3β and sFRP1 in human pancreatic carcinoma.
    Yang HW, Liu GH, Liu YQ, Zhao HC, Yang Z, Zhao CL, Zhang XF, Ye H.
    Biomed Pharmacother; 2016 Oct 28; 83():593-601. PubMed ID: 27459115
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway.
    Bai Z, Xia X, Lu J.
    Med Sci Monit; 2020 Jan 19; 26():e919241. PubMed ID: 31955177
    [Abstract] [Full Text] [Related]

  • 10. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F, Yin LX.
    Exp Mol Pathol; 2019 Feb 19; 106():34-43. PubMed ID: 30539797
    [Abstract] [Full Text] [Related]

  • 11. MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway.
    Huang M, Liao X, Li L, Li G, Chen M.
    Tissue Cell; 2021 Dec 19; 73():101672. PubMed ID: 34736163
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/β-Catenin Signaling.
    Hu Z, Wang P, Lin J, Zheng X, Yang F, Zhang G, Chen D, Xie J, Gao Z, Peng L, Xie C.
    Cell Physiol Biochem; 2018 Dec 19; 51(1):470-486. PubMed ID: 30453289
    [Abstract] [Full Text] [Related]

  • 13. RNF6 promotes colorectal cancer invasion and migration via the Wnt/β-catenin pathway by inhibiting GSK3β activity.
    Li Q, Wang G, Tao J, Chen W.
    Pathol Res Pract; 2021 Sep 19; 225():153545. PubMed ID: 34352441
    [Abstract] [Full Text] [Related]

  • 14. MiR-342 regulates cell proliferation and apoptosis in hepatocellular carcinoma through Wnt/β-catenin signaling pathway.
    Lu C, Jia S, Zhao S, Shao X.
    Cancer Biomark; 2019 Sep 19; 25(1):115-126. PubMed ID: 31006667
    [Abstract] [Full Text] [Related]

  • 15. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
    Sun J, Liu L, Zou H, Yu W.
    Yonsei Med J; 2019 Oct 19; 60(10):905-913. PubMed ID: 31538425
    [Abstract] [Full Text] [Related]

  • 16. RING finger and WD repeat domain 3 regulates proliferation and metastasis through the Wnt/β-catenin signalling pathways in hepatocellular carcinoma.
    Liang RP, Zhang XX, Zhao J, Lu QW, Zhu RT, Wang WJ, Li J, Bo K, Zhang CX, Sun YL.
    World J Gastroenterol; 2022 Jul 21; 28(27):3435-3454. PubMed ID: 36158256
    [Abstract] [Full Text] [Related]

  • 17. Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinoma.
    Wang Y, Sun L, Wang L, Liu Z, Li Q, Yao B, Wang C, Chen T, Tu K, Liu Q.
    Cell Death Dis; 2018 Aug 28; 9(9):851. PubMed ID: 30154476
    [Abstract] [Full Text] [Related]

  • 18. USP25 promotes hepatocellular carcinoma progression by interacting with TRIM21 via the Wnt/β-catenin signaling pathway.
    Liu Y, Ma J, Lu S, He P, Dong W.
    Chin Med J (Engl); 2023 Sep 20; 136(18):2229-2242. PubMed ID: 37439386
    [Abstract] [Full Text] [Related]

  • 19. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
    Zhang N, Chen X.
    Cell Oncol (Dordr); 2020 Feb 20; 43(1):137-153. PubMed ID: 31691159
    [Abstract] [Full Text] [Related]

  • 20. LncRNA RPPH1 acts as a molecular sponge for miR-122 to regulate Wnt1/β-catenin signaling in hepatocellular carcinoma.
    Zhou J, Shi K, Huang W, Zhang Y, Chen Q, Mou T, Wu Z, Wei X.
    Int J Med Sci; 2023 Feb 20; 20(1):23-34. PubMed ID: 36619232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.